Patrick D. Sutphin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patrick D. Sutphin has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Sanjeeva P. Kalva
Panel Chair, UT Southwestern Medical Center, Dallas, Texas
3 shared publicationsStephen P. Reis
Columbia University Medical Center, New York, New York
3 shared publicationsA. Tuba Kendi
Mayo Clinic, Rochester, Minnesota
2 shared publicationsAnil K. Pillai
University of Texas Southwestern, Dallas, Texas
2 shared publicationsBill S. Majdalany
Panel Vice-Chair, University of Michigan Health System, Ann Arbor, Michigan
2 shared publicationsJeremy D. Collins
Mayo Clinic, Rochester, Minnesota
2 shared publications
Latest Publications
- 1 May 2019
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 16 (5) , S2-S6
ACR Appropriateness Criteria® Abdominal Aortic Aneurysm Follow-up (Without Repair)
- 1 May 2019
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 16 (5) , S2-S6
ACR Appropriateness Criteria® Abdominal Aortic Aneurysm Follow-up (Without Repair)
- Open Access
- 1 December 2017
- Published by Georg Thieme Verlag KG
- Vol. 01 (S 04) , P010
Optimizing Cost and Workflow: A Quality Improvement Initiative in Outpatient Placement of Gastrostomy Tubes
Purpose The current practice for outpatient placement of percutaneous gastrostomy tubes (g-tubes) by interventional radiology (IR) at our institution is overnight admission and fluoroscopic g-tube check the next morning, prior to initiation of enteral feeding. Our primary objective is to examine the clinical need for routine admission and g-tube check after. Secondarily, we aim to quantify the potential cost savings of a policy change. Materials and Methods There are both IR and gastroenterology (GI) data, which shows no significant difference in complication rates between the same day discharge versus admission and also show safety in early enteral use of the g-tube in properly selected patients. While they are admitted, there should be a nutrition consult for not only teaching and use information, but also evaluating for risk of re-feeding syndrome in those patients who will be predominantly dependent on their g-tube for enteral nutrition. We questioned the need for routine admissions and fluoroscopic checks of the newly placed g-tubes on all patients. Results Ninety-three outpatients who underwent new g-tube placement from 2011 to 2016 were included. All the next day, fluoroscopic g-tube examinations were normal. Median and mean length of stay (LOS) were 1.0 and 1.6 days, respectively. Twenty-six percent had a LOS >1 day: 11 related to nutrition and 7 of 11 based on high risk of re-feeding syndrome (RFS) or laboratory evidence of RFS. Excluding patients with a LOS >1 day, the mean and median cost of visit was $8,524.89 and $6,104.35, respectively. Conclusion We found no indication for post-procedure g-tube checks or routine admission of all patients overnight. There were no changes in patient management based on normal results of g-tube check in 100% of patients. Regarding admission, those 7.5% of patients who were deemed high risk or developed RFS benefited from a planned admission. One change we propose is a nutrition consultation concurrent with a pre-procedure clinic visit to identify patients at risk for RFS that would benefit from a planned admission. The potential average cost savings in eliminating all post-procedure g-tube checks as well as routine admissions in low-risk patients would be $5,470 per patient in our population. This is based on an estimated average cost of medical supplies, procedure, and fluoroscopy suite time from a representative sampling of cost data. Our results are concordant with other data from both the IR and GI literature concluding that routine admission of all outpatient placements is not indicated.
- 1 December 2017
- Published by Georg Thieme Verlag KG
- Vol. 01 (S 04) , P010
Open AccessOptimizing Cost and Workflow: A Quality Improvement Initiative in Outpatient Placement of Gastrostomy Tubes
Purpose The current practice for outpatient placement of percutaneous gastrostomy tubes (g-tubes) by interventional radiology (IR) at our institution is overnight admission and fluoroscopic g-tube check the next morning, prior to initiation of enteral feeding. Our primary objective is to examine the clinical need for routine admission and g-tube check after. Secondarily, we aim to quantify the potential cost savings of a policy change. Materials and Methods There are both IR and gastroenterology (GI) data, which shows no significant difference in complication rates between the same day discharge versus admission and also show safety in early enteral use of the g-tube in properly selected patients. While they are admitted, there should be a nutrition consult for not only teaching and use information, but also evaluating for risk of re-feeding syndrome in those patients who will be predominantly dependent on their g-tube for enteral nutrition. We questioned the need for routine admissions and fluoroscopic checks of the newly placed g-tubes on all patients. Results Ninety-three outpatients who underwent new g-tube placement from 2011 to 2016 were included. All the next day, fluoroscopic g-tube examinations were normal. Median and mean length of stay (LOS) were 1.0 and 1.6 days, respectively. Twenty-six percent had a LOS >1 day: 11 related to nutrition and 7 of 11 based on high risk of re-feeding syndrome (RFS) or laboratory evidence of RFS. Excluding patients with a LOS >1 day, the mean and median cost of visit was $8,524.89 and $6,104.35, respectively. Conclusion We found no indication for post-procedure g-tube checks or routine admission of all patients overnight. There were no changes in patient management based on normal results of g-tube check in 100% of patients. Regarding admission, those 7.5% of patients who were deemed high risk or developed RFS benefited from a planned admission. One change we propose is a nutrition consultation concurrent with a pre-procedure clinic visit to identify patients at risk for RFS that would benefit from a planned admission. The potential average cost savings in eliminating all post-procedure g-tube checks as well as routine admissions in low-risk patients would be $5,470 per patient in our population. This is based on an estimated average cost of medical supplies, procedure, and fluoroscopy suite time from a representative sampling of cost data. Our results are concordant with other data from both the IR and GI literature concluding that routine admission of all outpatient placements is not indicated.
- Open Access
- 1 December 2017
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 01 (S 04) , P002
Translating Novel Nanotherapeutics into Treatment for Hepatocellular Carcinoma from Bench to Bedside: A Case Study of the LDL-DHA Nanoparticle
Introduction To examine an investigational nanomedicine and discuss the steps needed for clinical translation. For hepatocellular carcinoma (HCC), translating investigational therapies from the laboratory to the interventional radiology (IR) suite is complicated and expensive. We will examine the steps involved in obtaining approval of a novel drug with the low-density lipoprotein docosahexaenoic acid (LDL-DHA) nanoparticle as a case study for promising preclinical results in treating a rodent model of HCC. The agent has selective cytotoxicity toward HCC cells using redox-mediated processes, showing three-fold regression of tumor mass with no adverse effects on normal liver tissue. Content organization Preclinical Clinical Postmarket Learning Points With the success of transarterial therapies, we can expect to see newer agents for treating HCC. At a cost of roughly $1 billion over 10 to 15 years for the development of new drugs, investigators involved in creating embolics should understand the process and special considerations in translating nanotherapeutics into clinical use.
- 1 December 2017
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 01 (S 04) , P002
Open AccessTranslating Novel Nanotherapeutics into Treatment for Hepatocellular Carcinoma from Bench to Bedside: A Case Study of the LDL-DHA Nanoparticle
Introduction To examine an investigational nanomedicine and discuss the steps needed for clinical translation. For hepatocellular carcinoma (HCC), translating investigational therapies from the laboratory to the interventional radiology (IR) suite is complicated and expensive. We will examine the steps involved in obtaining approval of a novel drug with the low-density lipoprotein docosahexaenoic acid (LDL-DHA) nanoparticle as a case study for promising preclinical results in treating a rodent model of HCC. The agent has selective cytotoxicity toward HCC cells using redox-mediated processes, showing three-fold regression of tumor mass with no adverse effects on normal liver tissue. Content organization Preclinical Clinical Postmarket Learning Points With the success of transarterial therapies, we can expect to see newer agents for treating HCC. At a cost of roughly $1 billion over 10 to 15 years for the development of new drugs, investigators involved in creating embolics should understand the process and special considerations in translating nanotherapeutics into clinical use.
- 1 May 2017
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 14 (5) , S258-S265
ACR Appropriateness Criteria ® Pulsatile Abdominal Mass Suspected Abdominal Aortic Aneurysm
- 1 May 2017
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 14 (5) , S258-S265
ACR Appropriateness Criteria ® Pulsatile Abdominal Mass Suspected Abdominal Aortic Aneurysm
- 1 January 2017
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 37 (1) , 346-357
Noninvasive Physiologic Vascular Studies: A Guide to Diagnosing Peripheral Arterial Disease
Noninvasive physiologic vascular studies allow evaluation of the physiologic parameters of blood flow through segmental arterial pressures, Doppler waveforms, and pulse volume recordings to determine the site and severity of lower extremity peripheral arterial disease. Noninvasive physiologic vascular studies play an important role in the diagnosis and characterization in peripheral arterial disease (PAD) of the lower extremity. These studies evaluate the physiologic parameters of blood flow through segmental arterial pressures, Doppler waveforms, and pulse volume recordings. Collectively, they comprise a powerful toolset for defining the functionality of the arterial system, localizing the site of disease, and providing prognostic data. This technology has been widely adopted by diverse medical specialty practitioners, including radiologists, surgeons, cardiologists, and primary care providers. The use of these studies increased substantially between 2000 and 2010. Although they do not employ imaging, they remain a critical component for a comprehensive radiologic vascular laboratory. A strong presence of radiology in the diagnosis of PAD adds value in that radiologists have shifted to noninvasive alternatives to diagnostic catheter angiography (DCA), such as computed ...
- 1 January 2017
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 37 (1) , 346-357
Noninvasive Physiologic Vascular Studies: A Guide to Diagnosing Peripheral Arterial Disease
Noninvasive physiologic vascular studies allow evaluation of the physiologic parameters of blood flow through segmental arterial pressures, Doppler waveforms, and pulse volume recordings to determine the site and severity of lower extremity peripheral arterial disease. Noninvasive physiologic vascular studies play an important role in the diagnosis and characterization in peripheral arterial disease (PAD) of the lower extremity. These studies evaluate the physiologic parameters of blood flow through segmental arterial pressures, Doppler waveforms, and pulse volume recordings. Collectively, they comprise a powerful toolset for defining the functionality of the arterial system, localizing the site of disease, and providing prognostic data. This technology has been widely adopted by diverse medical specialty practitioners, including radiologists, surgeons, cardiologists, and primary care providers. The use of these studies increased substantially between 2000 and 2010. Although they do not employ imaging, they remain a critical component for a comprehensive radiologic vascular laboratory. A strong presence of radiology in the diagnosis of PAD adds value in that radiologists have shifted to noninvasive alternatives to diagnostic catheter angiography (DCA), such as computed ...
- 1 May 2016
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 27 (5) , 762-764
Expulsion of a Uterine Fibroid into the Small Bowel through Uteroenteric Fistula Presenting with Bowel Obstruction after Uterine Fibroid Embolization: Case Report with Histopathologic Correlation
- 1 May 2016
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 27 (5) , 762-764
Expulsion of a Uterine Fibroid into the Small Bowel through Uteroenteric Fistula Presenting with Bowel Obstruction after Uterine Fibroid Embolization: Case Report with Histopathologic Correlation
- 1 December 2015
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 12 (12) , 1337-1344
Approaching the Practice Quality Improvement Project in Interventional Radiology
- 1 December 2015
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 12 (12) , 1337-1344
Approaching the Practice Quality Improvement Project in Interventional Radiology
- 1 April 2015
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 26 (4) , 491-498.e1
Improving Inferior Vena Cava Filter Retrieval Rates with the Define, Measure, Analyze, Improve, Control Methodology
- 1 April 2015
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 26 (4) , 491-498.e1
Improving Inferior Vena Cava Filter Retrieval Rates with the Define, Measure, Analyze, Improve, Control Methodology
- 5 September 2014
- Published by Springer Nature
- p. 39-49
Radiation Safety